Condition

Kidney Transplant

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 17 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials17
Recruiting6
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

17 shown
Predicting Outcomes in Posttransplant Diabetes Mellitus Via microRNANCT07055984 · 2025-04-28
RECRUITING
Cardiovascular Risk in Children With Chronic Conditions StudyNCT07086989 · 2025-04-01
RECRUITING
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney TransplantNCT06832410 · 2025-03-31
RECRUITING
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)NCT06752577 · 2024-12-22
RECRUITING
Feasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Transplant Recipients (HEAL)NCT06640179 · 2024-12-17
RECRUITING
Empagliflozin Treatment in Kidney Transplant RecipientsNCT06013865 · 2024-04-05
RECRUITING
POTASSIUM-RICH SALT SUBSTITUTES IN KIDNEY TRANSPLANT RECIPIENTSNCT07178964 · 2025-10-01
NOT_YET_RECRUITING
Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing Type 2 DiabetesNCT07271433 · 2024-01-29
COMPLETED
Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy AdultsNCT04952766 · 2021-03-26
COMPLETED
NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney TransplantationNCT03866421 · 2019-05-29
TERMINATED
Impact of Sirolimus and Maraviroc on CCR5 Expression and the HIV-1 Reservoir in HIV-infected Kidney Transplant RecipientsNCT02990312 · 2017-05-01
WITHDRAWN
Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal TransplantNCT02464878 · 2017-01-01
COMPLETED
Impact of Everolimus on HIV Persistence Post Kidney or Liver TransplantNCT02429869 · 2016-02-24
COMPLETED
Melatonin and Adiponectin in Hypertensive Kidney TransplantNCT00498576 · 2007-09-01
COMPLETED
Sitagliptin Treatment in Patients With Type 2 DM After Kidney TransplantNCT00466518 · 2007-04-01
COMPLETED
Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)NCT00296296 · 2005-06-01
COMPLETED
Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation RecipientsNCT00171496 · 2003-10-01
COMPLETED

Common interventions

Trial status mix

COMPLETED8
RECRUITING6
NOT_YET_RECRUITING1
TERMINATED1
WITHDRAWN1

Phase mix

PHASE46
NA3
PHASE21
PHASE31
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.